IS6899A - Samsetning og andveiruvirkni tengdra azaindóloxóediksýru píperazín afleiða - Google Patents
Samsetning og andveiruvirkni tengdra azaindóloxóediksýru píperazín afleiðaInfo
- Publication number
- IS6899A IS6899A IS6899A IS6899A IS6899A IS 6899 A IS6899 A IS 6899A IS 6899 A IS6899 A IS 6899A IS 6899 A IS6899 A IS 6899A IS 6899 A IS6899 A IS 6899A
- Authority
- IS
- Iceland
- Prior art keywords
- azaindoleoxoacetic
- composition
- antiviral activity
- piperazine derivatives
- acid piperazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26618301P | 2001-02-02 | 2001-02-02 | |
| US31440601P | 2001-08-23 | 2001-08-23 | |
| PCT/US2002/000455 WO2002062423A1 (en) | 2001-02-02 | 2002-01-02 | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS6899A true IS6899A (is) | 2003-07-30 |
| IS2912B IS2912B (is) | 2014-11-15 |
Family
ID=26951680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS6899A IS2912B (is) | 2001-02-02 | 2003-07-30 | Samsetning og andveiruvirkni umskiptra azaindóloxóediksýrupíperazínafleiðna |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20030069266A1 (is) |
| EP (1) | EP1363705B9 (is) |
| JP (1) | JP4328527B2 (is) |
| KR (1) | KR20030079979A (is) |
| CN (1) | CN100384423C (is) |
| AR (1) | AR034292A1 (is) |
| BG (1) | BG66359B1 (is) |
| BR (1) | BRPI0206636B8 (is) |
| CA (1) | CA2437524C (is) |
| CY (1) | CY1113194T1 (is) |
| CZ (1) | CZ303750B6 (is) |
| DK (1) | DK1363705T3 (is) |
| EE (1) | EE05424B1 (is) |
| ES (1) | ES2387981T3 (is) |
| HK (1) | HK1056698A1 (is) |
| HR (1) | HRP20030694A2 (is) |
| HU (1) | HU229305B1 (is) |
| IL (2) | IL157029A0 (is) |
| IS (1) | IS2912B (is) |
| MX (1) | MXPA03006939A (is) |
| MY (1) | MY137480A (is) |
| NO (1) | NO326510B1 (is) |
| NZ (1) | NZ527193A (is) |
| PE (1) | PE20020855A1 (is) |
| PL (1) | PL364279A1 (is) |
| PT (1) | PT1363705E (is) |
| RS (1) | RS52489B (is) |
| RU (1) | RU2303038C2 (is) |
| SK (1) | SK287900B6 (is) |
| TW (1) | TWI318978B (is) |
| WO (1) | WO2002062423A1 (is) |
| ZA (1) | ZA200305885B (is) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6476034B2 (en) * | 2000-02-22 | 2002-11-05 | Bristol-Myers Squibb Company | Antiviral azaindole derivatives |
| US20030207910A1 (en) * | 2001-02-02 | 2003-11-06 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US20040110785A1 (en) * | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| EP1476163A4 (en) * | 2002-02-23 | 2009-05-27 | Bristol Myers Squibb Co | METHOD FOR TREATING HIV INFECTION BY PREVENTING INTERACTION OF CD4 AND GP120 |
| US7348337B2 (en) | 2002-05-28 | 2008-03-25 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| US6900206B2 (en) | 2002-06-20 | 2005-05-31 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| NZ540148A (en) | 2002-12-20 | 2007-11-30 | Glaxo Group Ltd | Benzazepine derivatives for the treatment of neurological disorders |
| US20050075364A1 (en) * | 2003-07-01 | 2005-04-07 | Kap-Sun Yeung | Indole, azaindole and related heterocyclic N-substituted piperazine derivatives |
| US20050124623A1 (en) * | 2003-11-26 | 2005-06-09 | Bender John A. | Diazaindole-dicarbonyl-piperazinyl antiviral agents |
| UA88297C2 (ru) * | 2004-03-15 | 2009-10-12 | Бристол-Майэрс Сквибб Компани | Пиперазиновые пролекарства и замещенные пиперидиновые антивирусные средства |
| US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| US20050244458A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
| DE602005010698D1 (de) | 2004-06-09 | 2008-12-11 | Glaxo Group Ltd | Pyrrolopyridinderivate |
| CA2579127C (en) | 2004-09-03 | 2011-08-02 | Yuhan Corporation | Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof |
| US20060100209A1 (en) * | 2004-11-09 | 2006-05-11 | Chong-Hui Gu | Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
| US20060100432A1 (en) * | 2004-11-09 | 2006-05-11 | Matiskella John D | Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
| US7183284B2 (en) * | 2004-12-29 | 2007-02-27 | Bristol-Myers Squibb Company | Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
| US7601715B2 (en) | 2005-06-22 | 2009-10-13 | Bristol-Myers Squibb Company | Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
| US7396830B2 (en) * | 2005-10-04 | 2008-07-08 | Bristol-Myers Squibb Company | Piperazine amidines as antiviral agents |
| US7851476B2 (en) * | 2005-12-14 | 2010-12-14 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine |
| US7807671B2 (en) * | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
| US7504399B2 (en) * | 2006-06-08 | 2009-03-17 | Bristol-Meyers Squibb Company | Piperazine enamines as antiviral agents |
| EP2046753A2 (en) * | 2006-07-06 | 2009-04-15 | Brystol-Myers Squibb Company | Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| EP2066664A1 (en) * | 2006-09-22 | 2009-06-10 | Novartis AG | Heterocyclic organic compounds |
| ES2462403T3 (es) | 2008-06-25 | 2014-05-22 | Bristol-Myers Squibb Company | Diceto azolopiperidinas y azolopiperazinas como agentes anti-VIH |
| WO2009158396A1 (en) | 2008-06-25 | 2009-12-30 | Bristol-Myers Squibb Company | Diketopiperidine derivatives as hiv attachment inhibitors |
| WO2012019003A1 (en) | 2010-08-06 | 2012-02-09 | Bristol-Myers Squibb Company | Substituted indole and azaindole oxoacetyl piperazinamide derivatives |
| EP2646439B1 (en) | 2010-12-02 | 2016-05-25 | Bristol-Myers Squibb Company | Alkyl amides as hiv attachment inhibitors |
| US8685982B2 (en) | 2011-04-12 | 2014-04-01 | Bristol-Myers Squibb Company | Thioamide, amidoxime and amidrazone derivatives as HIV attachment inhibitors |
| ES2609579T3 (es) | 2011-08-29 | 2017-04-21 | VIIV Healthcare UK (No.5) Limited | Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH |
| EP2751119B1 (en) | 2011-08-29 | 2016-11-23 | VIIV Healthcare UK (No.5) Limited | Fused bicyclic diamine derivatives as hiv attachment inhibitors |
| ES2644747T3 (es) | 2012-02-08 | 2017-11-30 | Viiv Healthcare Uk (No. 4) Limited | Procedimientos de preparación de un compuesto de profármaco de piperazina inhibidor de la fijación del VIH |
| WO2013138436A1 (en) | 2012-03-14 | 2013-09-19 | Bristol-Myers Squibb Company | Cyclolic hydrazine derivatives as hiv attachment inhibitors |
| WO2014060381A1 (de) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Heterocyclische verbindungen als schädlingsbekämpfungsmittel |
| EP2914587A1 (de) | 2012-10-31 | 2015-09-09 | Bayer CropScience AG | Neue heterocylische verbindungen als schädlingsbekämpfungsmittel |
| WO2016004272A1 (en) | 2014-07-02 | 2016-01-07 | Pharmacyclics Llc | Inhibitors of bruton's tyrosine kinase |
| US11862306B1 (en) | 2020-02-07 | 2024-01-02 | Cvs Pharmacy, Inc. | Customer health activity based system for secure communication and presentation of health information |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5563142A (en) * | 1989-12-28 | 1996-10-08 | The Upjohn Company | Diaromatic substituted compounds as anti-HIV-1 agents |
| GB9420521D0 (en) * | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
| TW406075B (en) * | 1994-12-13 | 2000-09-21 | Upjohn Co | Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds |
| BR0011274A (pt) * | 1999-05-21 | 2002-02-26 | Scios Inc | Derivados tipo indol como inibidores de p38 quinase |
| US6469006B1 (en) * | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
| JP4829449B2 (ja) * | 1999-07-28 | 2011-12-07 | アベンティス・ファーマスーティカルズ・インコーポレイテツド | 置換オキソアザヘテロシクリル化合物 |
| CA2699568C (en) * | 1999-12-24 | 2013-03-12 | Aventis Pharma Limited | Azaindoles |
| US20020061892A1 (en) * | 2000-02-22 | 2002-05-23 | Tao Wang | Antiviral azaindole derivatives |
| DK1299382T3 (da) * | 2000-07-10 | 2006-01-16 | Bristol Myers Squibb Co | Præparat og antiviral virkning af substituerede indoloxoeddikesyrepiperazinderivater |
| US6825201B2 (en) * | 2001-04-25 | 2004-11-30 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
-
2002
- 2002-01-02 EP EP02707413A patent/EP1363705B9/en not_active Expired - Lifetime
- 2002-01-02 RU RU2003127077/04A patent/RU2303038C2/ru active
- 2002-01-02 KR KR10-2003-7010208A patent/KR20030079979A/ko not_active Application Discontinuation
- 2002-01-02 PT PT02707413T patent/PT1363705E/pt unknown
- 2002-01-02 EE EEP200300359A patent/EE05424B1/xx unknown
- 2002-01-02 WO PCT/US2002/000455 patent/WO2002062423A1/en active IP Right Grant
- 2002-01-02 NZ NZ527193A patent/NZ527193A/en not_active IP Right Cessation
- 2002-01-02 DK DK02707413.7T patent/DK1363705T3/da active
- 2002-01-02 PL PL02364279A patent/PL364279A1/xx unknown
- 2002-01-02 RS YU60903A patent/RS52489B/en unknown
- 2002-01-02 BR BR0206636-0 patent/BRPI0206636B8/pt not_active IP Right Cessation
- 2002-01-02 MX MXPA03006939A patent/MXPA03006939A/es active IP Right Grant
- 2002-01-02 ES ES02707413T patent/ES2387981T3/es not_active Expired - Lifetime
- 2002-01-02 HU HU0304062A patent/HU229305B1/hu unknown
- 2002-01-02 CA CA2437524A patent/CA2437524C/en not_active Expired - Lifetime
- 2002-01-02 SK SK959-2003A patent/SK287900B6/sk not_active IP Right Cessation
- 2002-01-02 US US10/038,306 patent/US20030069266A1/en not_active Abandoned
- 2002-01-02 JP JP2002562428A patent/JP4328527B2/ja not_active Expired - Lifetime
- 2002-01-02 IL IL15702902A patent/IL157029A0/xx unknown
- 2002-01-02 CZ CZ20032316A patent/CZ303750B6/cs not_active IP Right Cessation
- 2002-01-02 CN CNB028078268A patent/CN100384423C/zh not_active Expired - Lifetime
- 2002-01-18 MY MYPI20020202A patent/MY137480A/en unknown
- 2002-01-23 TW TW091101013A patent/TWI318978B/zh not_active IP Right Cessation
- 2002-01-31 AR ARP020100336A patent/AR034292A1/es active IP Right Grant
- 2002-02-01 PE PE2002000075A patent/PE20020855A1/es not_active Application Discontinuation
-
2003
- 2003-07-21 IL IL157029A patent/IL157029A/en active IP Right Grant
- 2003-07-22 BG BG108021A patent/BG66359B1/bg unknown
- 2003-07-30 ZA ZA2003/05885A patent/ZA200305885B/en unknown
- 2003-07-30 IS IS6899A patent/IS2912B/is unknown
- 2003-08-01 NO NO20033436A patent/NO326510B1/no not_active IP Right Cessation
- 2003-09-01 HR HR20030694A patent/HRP20030694A2/hr not_active Application Discontinuation
- 2003-12-12 HK HK03109083.6A patent/HK1056698A1/xx not_active IP Right Cessation
-
2012
- 2012-09-12 CY CY20121100828T patent/CY1113194T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS6899A (is) | Samsetning og andveiruvirkni tengdra azaindóloxóediksýru píperazín afleiða | |
| IS7682A (is) | Samsetning og andveiruvirkni skiptitengdra azaindóloxóediksýru píperazín afleiðna | |
| IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
| DE60123210D1 (de) | Picolinsäure-derivate und ihre verwendung als fungizide | |
| DK1578755T3 (da) | Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse | |
| DE50202479D1 (de) | Saure pigmentdispergatoren und pigmentzubereitungen | |
| NO20014409D0 (no) | Dimere forbindelser og deres anvendelse som inhibitorer av neuraminidase | |
| DE60201859D1 (de) | Pharmazeutische Verwendung von N-Carbamoylazol-Derivate | |
| IS6477A (is) | Afleiður piperazíns og piperadíns | |
| DE60111430D1 (de) | Hypochlorige säure zusammensetzung und ihre verwendungen | |
| PT1446399E (pt) | Derivados de piperazina tendo actividade antagonista de sst1 | |
| DE60008807D1 (de) | Binaphtol-monophosphorsäurederivate und deren Verwendung | |
| DK1231933T3 (da) | Vandig oplösningsformulering af alfa-interferon | |
| IL163959A (en) | Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them | |
| DK1228026T3 (da) | 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse | |
| NO20034172L (no) | Bisykliske guanidinderivater og terapeutiske anvendelser derav | |
| PT1392670E (pt) | Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina | |
| HK1073243A1 (en) | Use of N-(indolecarbonyl-) piperazine derivatives | |
| SI1363705T1 (sl) | Sestavek in antivirusna aktivnost substituiranih azaindoleoksoocetnih piperazinskih derivatov | |
| DE60336549D1 (de) | Hepatoprotektor aktivität von 2'-p-hydroxybenzoylmussaenosidsäure | |
| TH103167B (th) | สารผสมและแอคติวิตีต้านไวรัสของอนุพันธ์อะซาอินโดลออกโซอะซีติกพิเพอราซีนซึ่งถูกแทนที่ | |
| DE60103678D1 (de) | Derivate der Äpfelsäure und der Oxalessigsäure | |
| FI20000395A (fi) | N-(amidinobentsoyyli- tai amidinopyridyylikarbonyyli)-alfa-aminohappojohdannaisia | |
| SE0202986D0 (sv) | Naphthamide derivatives and their use |